Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38,284 | 31,726 | 55,616 | 56,753 | 63,030 |
| Marketable Securities | 65,352 | 67,893 | 40,863 | 41,362 | 30,137 |
| Receivables | 26,329 | 53,654 | 33,565 | 25,910 | 25,172 |
| Inventories | 8,693 | 5,515 | 9,476 | 8,591 | 8,751 |
| Other current assets | 196 | 256 | 230 | 73 | 98 |
| TOTAL | $142,259 | $162,686 | $143,580 | $136,578 | $132,510 |
| Non-Current Assets | |||||
| PPE Net | 124 | 187 | 305 | 388 | 474 |
| Intangibles | 38,957 | 41,392 | 43,827 | 46,262 | 48,697 |
| Other Non-Current Assets | 11,359 | 12,037 | 15,150 | 11,688 | 14,500 |
| TOTAL | $50,440 | $53,616 | $59,282 | $58,338 | $63,671 |
| Total Assets | $192,699 | $216,302 | $202,862 | $194,916 | $196,181 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 11,283 | 22,523 | 33,716 | 33,997 | 45,329 |
| Accounts payable and accrued liabilities | 8,166 | 5,056 | 6,386 | 5,424 | 6,026 |
| Accrued Expenses | 38,378 | 50,031 | 37,116 | 31,797 | 26,873 |
| Other current liabilities | 1,785 | 2,329 | 3,040 | 3,517 | 2,697 |
| TOTAL | $59,737 | $81,253 | $82,728 | $79,099 | $86,663 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 10,869 | 10,647 |
| Other Non-Current Liabilities | 4,546 | 4,709 | 4,866 | 230 | 1,763 |
| TOTAL | $4,546 | $4,709 | $4,866 | $11,099 | $12,410 |
| Total Liabilities | $64,283 | $85,962 | $87,594 | $90,198 | $99,073 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50,899 | 50,876 | 50,391 | 50,371 | 49,638 |
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | -1,287,528 | -1,283,775 | -1,297,213 | -1,306,057 | -1,311,912 |
| Other shareholders' equity | -31 | 36 | 19 | -14 | -11 |
| TOTAL | $128,416 | $130,340 | $115,268 | $104,718 | $97,108 |
| Total Liabilities And Equity | $192,699 | $216,302 | $202,862 | $194,916 | $196,181 |